Lu Y - Search Results

1

Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types.

Routh ED, Pullikuth AK, Jin G, Chifman J, Chou JW, D'Agostino RB Jr, Seino KI, Wada H, Print CG, Zhang W, Lu Y, Miller LD. Routh ED, et al. Among authors: lu y. Front Immunol. 2020 Feb 13;11:57. doi: 10.3389/fimmu.2020.00057. eCollection 2020. Front Immunol. 2020. PMID: 32117236 Free PMC article.

2

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes.

Pullikuth AK, Routh ED, Zimmerman KD, Chifman J, Chou JW, Soike MH, Jin G, Su J, Song Q, Black MA, Print C, Bedognetti D, Howard-McNatt M, O'Neill SS, Thomas A, Langefeld CD, Sigalov AB, Lu Y, Miller LD. Pullikuth AK, et al. Among authors: lu y. Front Oncol. 2021 Dec 8;11:734959. doi: 10.3389/fonc.2021.734959. eCollection 2021. Front Oncol. 2021. PMID: 34956864 Free PMC article.

3

IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling.

Xue G, Jin G, Fang J, Lu Y. Xue G, et al. Among authors: lu y. Nat Commun. 2019 Mar 26;10(1):1376. doi: 10.1038/s41467-019-09401-9. Nat Commun. 2019. PMID: 30914642 Free PMC article.

4

Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq.

Song Q, Hawkins GA, Wudel L, Chou PC, Forbes E, Pullikuth AK, Liu L, Jin G, Craddock L, Topaloglu U, Kucera G, O'Neill S, Levine EA, Sun P, Watabe K, Lu Y, Alexander-Miller MA, Pasche B, Miller LD, Zhang W. Song Q, et al. Among authors: lu y. Cancer Med. 2019 Jun;8(6):3072-3085. doi: 10.1002/cam4.2113. Epub 2019 Apr 29. Cancer Med. 2019. PMID: 31033233 Free PMC article.

5

hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy.

Lu Y, Xue G, Zheng N, Han K, Yang W, Wang RS, Wu L, Miller LD, Pardee T, Triozzi PL, Lo HW, Watabe K, Wong STC, Pasche BC, Zhang W, Jin G. Lu Y, et al. Brief Bioinform. 2022 Mar 10;23(2):bbab575. doi: 10.1093/bib/bbab575. Brief Bioinform. 2022. PMID: 35037026 Free PMC article.

6

Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells.

Xue G, Zheng N, Fang J, Jin G, Li X, Dotti G, Yi Q, Lu Y. Xue G, et al. Among authors: lu y. Cancer Cell. 2021 Dec 13;39(12):1610-1622.e9. doi: 10.1016/j.ccell.2021.09.011. Epub 2021 Oct 21. Cancer Cell. 2021. PMID: 34678150 Free PMC article.

7

Speed and Location Both Matter: Antigen Stimulus Dynamics Controls CAR-T Cell Response.

Liu C, Qi T, Milner JJ, Lu Y, Cao Y. Liu C, et al. Among authors: lu y. Front Immunol. 2021 Oct 8;12:748768. doi: 10.3389/fimmu.2021.748768. eCollection 2021. Front Immunol. 2021. PMID: 34691062 Free PMC article.

8

Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance.

Zheng N, Fang J, Xue G, Wang Z, Li X, Zhou M, Jin G, Rahman MM, McFadden G, Lu Y. Zheng N, et al. Among authors: lu y. Cancer Cell. 2022 Sep 12;40(9):973-985.e7. doi: 10.1016/j.ccell.2022.08.001. Epub 2022 Aug 25. Cancer Cell. 2022. PMID: 36027915 Free PMC article.

9

VOC-alarm: mutation-based prediction of SARS-CoV-2 variants of concern.

Zhao H, Han K, Gao C, Madhira V, Topaloglu U, Lu Y, Jin G. Zhao H, et al. Among authors: lu y. Bioinformatics. 2022 Jul 11;38(14):3549-3556. doi: 10.1093/bioinformatics/btac370. Bioinformatics. 2022. PMID: 35640977 Free PMC article.

10

Targeting the IL-9 pathway in cancer immunotherapy.

Zheng N, Lu Y. Zheng N, et al. Among authors: lu y. Hum Vaccin Immunother. 2020 Oct 2;16(10):2333-2340. doi: 10.1080/21645515.2019.1710413. Epub 2020 Feb 10. Hum Vaccin Immunother. 2020. PMID: 32040369 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,311 results

Search Page